Abstract:Purpose: Both polymer micelles and mesoporous silica nanoparticles have been widely researched as vectors for small molecular insoluble drugs. To combine the advantages of copolymers and silica, studies on the preparation of copolymer-silica composites and cellular evaluation were carried out. Methods: First, a stearic acid-g-chitosan (CS-SA) copolymer was synthesized through a coupling reaction, and then silicone oxide (SiO2)-deposited doxorubicin (DOX)-loaded stearic acid-g-chitosan (CS-SA/SiO2/DOX) nanoparticles were prepared through the sol-gel reaction. Physical and chemical properties such as particle size, zeta potential, and morphologies were examined, and small-angle X-ray scattering (SAXS) analysis was employed to identify the mesoporous structures of the generated nanoparticles. Cellular uptake and cytotoxicity studies were also conducted. Results: CS-SA/SiO2/DOX nanoparticles with different amounts of SiO2 deposited were obtained, and SAXS studies showed that mesoporous structures existed in the CS-SA/SiO2/DOX nanoparticles. The mesoporous size of middle-ratio and high-ratio deposited CS-SA/SiO2/DOX nanoparticles were 4-5 nm and 8-10 nm, respectively. Based on transmission electron microscopy images of CS-SA/SiO2/DOX nanoparticles, dark rings around the nanoparticles could be observed in contrast with CS-SA/DOX micelles. Furthermore, CS-SA/SiO2/DOX nanoparticles exhibited faster release behavior in vitro than CS-SA/DOX micelles; cellular uptake research in A549 indicated that the CS-SA/SiO2/DOX nanoparticles were taken up by A549 cells more rapidly, and that CS-SA/SiO2/DOX nanoparticles entered the cell more easily when the amount of SiO2 was higher. IC50 values of CS-SA/DOX micelles, CS-SA/SiO2/DOX-4, CS-SA/SiO2/DOX-8, and CS-SA/SiO2/DOX-16 nanoparticles against A549 cells measured using the MTT assay were 1.69, 0.93, 0.32, and 0.12 mu g/mL, respectively. Conclusion: SiO2-deposited stearic acid-g-chitosan organic-inorganic composites show promise as nanocarriers for hydrophobic drugs such as DOX.

Self-assembled Nanoparticles Based on Hydrophobically Modified Chitosan As Carriers for Doxorubicin.

Effect of Molecular Weight on the Oleoyl-Chitosan Nanoparticles As Carriers for Doxorubicin.

Investigation of Polymeric Amphiphilic Nanoparticles As Antitumor Drug Carriers

Self-Assembled Nanoparticles Based on Galactosylated O-Carboxymethyl Chitosan-Graft-Stearic Acid Conjugates for Delivery of Doxorubicin

Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.

Ph-Sensitive Chitosan-Derived Nanoparticles As Doxorubicin Carriers for Effective Anti-Tumor Activity: Preparation and in Vitro Evaluation.

Self-assembled micelles based on Chondroitin sulfate/poly (d,l-lactideco-glycolide) block copolymers for doxorubicin delivery

Synthesis and Evaluation of Ph-Sensitive, Self-Assembled Chitosan-Based Nanoparticles As Efficient Doxorubicin Carriers

Synthesis and properties of pH sensitive carboxymethylated hydroxypropyl chitosan nanocarriers for delivery of doxorubicin

Chitosan-Alginate Nanoparticle System Efficiently Delivers Doxorubicin to MCF-7 Cells

Nanoparticles of deoxycholic acid, polyethylene glycol and folic acid-modified chitosan for targeted delivery of doxorubicin

Preparation of Doxorubicin Loaded Self-Aggregated Nanoparticles Based on Cholesterol-Modified Glycol Chitosan Conjugate and Its Pharmacokinetics in Rats

Synthesis and characterization of amphiphilic glycidol-chitosan-deoxycholic acid nanoparticles as a drug carrier for doxorubicin.

Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- Caprolactone) Bearing Pendant Hydroxyl Groups As Nanocarriers for Doxorubicin Delivery.

Chitosan functionalized doxorubicin loaded poly(methacrylamide) based copolymeric nanoparticles for enhanced cellular internalization and in vitro anticancer evaluation

Hybrid Nanoparticles Based on Ortho Ester-Modified Pluronic L61 and Chitosan for Efficient Doxorubicin Delivery

Chitosan oligosaccharide-arachidic acid-based nanoparticles for anti-cancer drug delivery

In Vitro Evaluation of Polymeric Micelles Based on Hydrophobically-Modified Sulfated Chitosan As a Carrier of Doxorubicin

Enhanced Therapeutic Efficacy of Doxorubicin for Breast Cancer Using Chitosan Oligosaccharide-Modified Halloysite Nanotubes.

Self-Assembled Hyaluronic Acid Nanoparticles for Ph-Sensitive Release of Doxorubicin: Synthesis and in Vitro Characterization.

Preparation and evaluation of SiO2-deposited stearic acid-g-chitosan nanoparticles for doxorubicin delivery.